Respiratory Medicine
Volume 104, Issue 3 , Pages 412-417 , March 2010

Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: A pilot study

  • Franco Pasqua

      Affiliations

    • Division of Pulmonary Rehabilitation, San Raffaele Hospital, Velletri (Rome), Italy
    • ,
  • Gianluca Biscione

      Affiliations

    • Division of Pulmonary Rehabilitation, San Raffaele Hospital, Velletri (Rome), Italy
    • ,
  • Girolmina Crigna

      Affiliations

    • Division of Pulmonary Rehabilitation, San Raffaele Hospital, Velletri (Rome), Italy
    • ,
  • Laura Auciello

      Affiliations

    • Division of Pulmonary Rehabilitation, San Raffaele Hospital, Velletri (Rome), Italy
    • ,
  • Mario Cazzola

      Affiliations

    • Division of Respiratory Medicine and Unit of Respiratory Clinical Pharmacology, Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy
    • Corresponding Author InformationCorresponding author at: Dipartimento di Medicina Interna, Università di Roma Tor Vergata, Via Montpellier 1, 00133 Roma, Italy.

Received 21 August 2009 ,Accepted 6 October 2009.

References 

  1. Pepin V, Laviolette L, Saey D, Maltais F. Synergetic interactions between rehabilitation and pharmacotherapy in COPD. Clin Invest Med. 2006;29:170–177
  2. Plankeel JF, McMullen B, MacIntyre NR. Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non−oxygen−dependent COPD patients. Chest. 2005;127:110–116
  3. American Thoracic Society . Pulmonary rehabilitation. Am J Respir Crit Care Med. 1999;159:1666–1682
  4. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(4):CD003793
  5. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555
  6. Casaburi R, Kukafka D, Cooper CB, Witek TJ, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127:809–817
  7. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:19–38
  8. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33:262–272
  9. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511–522
  10. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General considerations for lung function testing. Eur Respir J. 2005;26:153–161
  11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
  12. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381
  13. Cazzola M, Di Marco F, Santus P, Boveri B, Verga M, Matera MG, et al. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther. 2004;17:35–39
  14. Freiman JA, Chalmers TC, Smith H, Kuebler R. The importance of β, the type II error, and sample size in the design and interpretation of the randomized controlled trial. In:  Bailar JC,  Mosteller F editor. Medical uses of statistics. Boston, Ma: NEJM Books; 1992;p. 357–373
  15. Geddes EL, Reid WD, Crowe J, O'Brien K, Brooks D. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review. Respir Med. 2005;99:1440–1458
  16. Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance. Int J Chron Obstruct Pulmon Dis. 2008;3:771–780
  17. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–789
  18. Troosters T, Gosselink R, Decramer M. Short− and long−term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med. 2000;109:207–212
  19. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta−analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007;43:475–485
  20. Pepin V, Brodeur J, Lacasse Y, Milot J, Leblanc P, Whittom F, et al. Six−minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax. 2007;62:291–298
  21. Morgan MD, Singh SJ. Assessing the exercise response to a bronchodilator in COPD: time to get off your bike?. Thorax. 2007;62:281–283
  22. Cazzola M, Biscione GL, Pasqua F, Crigna G, Appodia M, Cardaci V, et al. Use of 6−min and 12−min walking test for assessing the efficacy of formoterol in COPD. Respir Med. 2008;102:1425–1430
  23. Vagaggini B, Costa F, Antonelli S, De Simone C, De Cusatis G, Martino F, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med. 2009;103:1224–1230
  24. McKay SE, Howie CA, Thomson AH, Whiting B, Addis GJ. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. Thorax. 1993;48:227–232
  25. Jaeschke R, Guyatt GH, Willan A, Cook D, Harper S, Morris J, et al. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax. 1994;49:479–484
  26. Cazzola M, Andò F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, et al. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe−to−very severe COPD. Pulm Pharmacol Ther. 2007;20:556–561
  27. Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax. 2008;63:592–598
  28. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31:416–469

PII: S0954-6111(09)00326-6

doi: 10.1016/j.rmed.2009.10.005

Respiratory Medicine
Volume 104, Issue 3 , Pages 412-417 , March 2010

Article Tools

* Image Usage & Resolution